Quest Diagnostics (NYSE:DGX) Sets New 1-Year High - What's Next?

robot
Abstract generation in progress

Quest Diagnostics (NYSE:DGX) recently achieved a new 52-week high of $213.40, following strong quarterly earnings that surpassed analyst expectations and a board-approved $1.00 billion share buyback program. The company also increased its quarterly dividend to $0.86, representing a $3.44 annual dividend and a ~1.6% yield. Despite mixed analyst ratings, the consensus remains a “Moderate Buy” with a mean target of $210.29, and several firms have raised their price targets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments